The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tremelimumab, a fully human anti-CTLA-4 monoclonal antibody, optimal dosing regimen for patients with unresectable malignant mesothelioma (MM).
 
Rajesh Narwal
Employment - MedImmune; MedImmune (I)
Stock and Other Ownership Interests - MedImmune; MedImmune (I)
 
Alessandra DiPietro
Employment - MedImmune
 
Ramy Ibrahim
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Luana Calabrò
Research Funding - MedImmune (Inst)
 
Michele Maio
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
 
Paul B. Robbins
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Lorin Roskos
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
Patents, Royalties, Other Intellectual Property - MedImmune (Inst)
Travel, Accommodations, Expenses - MedImmune